Streamlining antimicrobial therapy for lower respiratory tract infections

Area of Science:

• Infectious Diseases
• Pharmacology
• Hospital Administration

Background:

• Antimicrobial therapy is crucial for lower respiratory tract infections (LRTI).
• Empirical broad-spectrum antibiotic use is common pending pathogen identification.
• Catheter-associated complications and costs are significant concerns in hospitalized patients.

Purpose of the Study:

• To evaluate the safety and efficacy of antimicrobial streamlining in hospitalized LRTI patients.
• To highlight the benefits of converting from broad-spectrum empirical therapy to narrower, oral agents.
• To assess the feasibility of early intravenous to oral antibiotic conversion.

Main Methods:

• Review of current antimicrobial stewardship practices.
• Analysis of clinical data supporting early conversion to oral therapy.
• Consideration of pharmacokinetic and pharmacodynamic profiles of newer oral agents.

Main Results:

• Antimicrobial streamlining reduces catheter-associated bacteremias and phlebitis by enabling early catheter removal.
• Newer oral agents (fluoroquinolones, macrolides/azalides, cephalosporins) facilitate effective streamlining.
• Data suggest rapid conversion from intravenous to oral antimicrobial therapy is safe and effective for appropriate LRTI patients.

Conclusions:

• Antimicrobial streamlining provides significant patient and hospital benefits.
• Early conversion to oral therapy is a viable and recommended strategy for hospitalized LRTI patients.
• Optimizing antimicrobial regimens improves patient outcomes and reduces healthcare costs.